Free Trial
ASX:COH

Cochlear (COH) Stock Price, News & Analysis

Cochlear logo

About Cochlear Stock (ASX:COH)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
201,277 shs
Average Volume
N/A
Market Capitalization
A$19.88 billion
P/E Ratio
55.90
Dividend Yield
1.35%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive COH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

COH Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
Cochlear Limited Updates on Ongoing Buy-Back Program
Cochlear Limited Announces Hybrid Format for 2025 AGM
See More Headlines

COH Stock Analysis - Frequently Asked Questions

Cochlear Limited (ASX:COH) issued its earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share for the quarter, missing the consensus estimate of $2.19 by $0.04. Cochlear had a net margin of 15.80% and a trailing twelve-month return on equity of 19.70%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE).

Company Calendar

Last Earnings
2/19/2019
Ex-Dividend for 10/12 Dividend
9/17/2025
Today
10/09/2025
Record date for 10/12 Dividend
10/12/2025
Dividend Payable
10/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:COH
CIK
N/A
Fax
N/A
Employees
4,996
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$5.43
Trailing P/E Ratio
55.90
Forward P/E Ratio
N/A
P/E Growth
3.87
Net Income
A$356.80 million
Net Margins
15.80%
Pretax Margin
N/A
Return on Equity
19.70%
Return on Assets
11.99%

Debt

Debt-to-Equity Ratio
13.24
Current Ratio
2.30
Quick Ratio
1.93

Sales & Book Value

Annual Sales
A$2.24 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
123.45
Book Value
A$28.10 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
65,500,000
Free Float
N/A
Market Cap
A$19.88 billion
Optionable
Not Optionable
Beta
0.47
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (ASX:COH) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners